Stocks
Daxor CorporationDXR
NASDAQHealthcareMedical Devices$10.05
Price as of · delayed, not real-time
A developer and marketer of blood volume measurement technology, primarily through its BVA-100 diagnostic system, which aids in managing fluid balance in critical care and surgical settings. The company also operates a blood bank and plasma center, generating revenue from blood products and services. Investors track Daxor for its niche position in medical diagnostics and its ongoing efforts to commercialize its proprietary technology.
52W Range: $8.56-$14.76
Congressional Interest in Daxor Corporation (DXR)
2 members of Congress have disclosed 2 trades in Daxor Corporation (DXR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading DXR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-08-05 | Rohit Khanna | sell | $1K-$15K |
| 2016-08-26 | MICHAEL T. MCCAUL | buy | $1K-$15K |